2005
DOI: 10.1182/blood-2004-08-3296
|View full text |Cite
|
Sign up to set email alerts
|

Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions

Abstract: Mutations of the perforin (PRF1) and MUNC13-4 genes distinguish 2 forms of familial hemophagocytic lymphohistiocytosis (FHL2 and FHL3, respectively)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
106
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 124 publications
(111 citation statements)
references
References 33 publications
5
106
0
Order By: Relevance
“…Late onset of HLH has been described in patients with perforin, [17][18][19][20][22][23][24][25]36 SYNTAXIN11, [14][15][16] MUNC13-4 27-29 and MUNC18-2 deficiency. 7,8 While lateonset FHL-2 patients mostly carry missense mutations, late onset of FHL-3 is predominantly associated with splice-site mutations and in late-onset FHL-4 patients also nonsense mutations and deletions have been described.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Late onset of HLH has been described in patients with perforin, [17][18][19][20][22][23][24][25]36 SYNTAXIN11, [14][15][16] MUNC13-4 27-29 and MUNC18-2 deficiency. 7,8 While lateonset FHL-2 patients mostly carry missense mutations, late onset of FHL-3 is predominantly associated with splice-site mutations and in late-onset FHL-4 patients also nonsense mutations and deletions have been described.…”
Section: Discussionmentioning
confidence: 99%
“…These atypical presentations have been reported in adolescents and even in adults as late as 62 years of age. 7,8,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29] They may be associated with milder and often recurrent HLH episodes and prolonged survival in the absence of hematopoietic stem cell transplantation (HSCT), which is unusual in patients with the typical disease. "Atypical FHL" is usually associated with missense or splice-site mutations in the affected genes.…”
Section: Introductionmentioning
confidence: 99%
“…Three patients with FHL3 in our series (38%) had CNS involvement at initial diagnosis, which is lower than previously reported rates (range, 60% -90%). 16,27,30 CNS involvement is the most discouraging clinical manifestation in FHL, and the association of CNS involvement with FHL3 might be related to the role of UNC13D in CNS function. 34 Two of these three patients succumbed to the disease, and also the single patient with FHL2 developed CNS involvement and died during the course of HLH-2004 treatment.…”
Section: © F E R R a T A S T O R T I F O U N D A T I O Nmentioning
confidence: 99%
“…15,24 Among Asian countries, data on the molecular genetics of FHL are available only from Japan; 18,19,26,27 FHL2 and FHL3 accounted for approximately 19% and between 20% and 25% of cases of FHL in Japan, respectively. This contrasts with our result that FHL3 accounted for 89% of cases of FHL in Korea.…”
Section: © F E R R a T A S T O R T I F O U N D A T I O Nmentioning
confidence: 99%
“…The gene product associated with the PRF1 nonsense mutation 1090-1091delCT present in this patient has been reported to produce a band of 55 kDa under reducing conditions and no band under non-reducing condition. 8,9 Under reducing conditions, the patient's CTL showed a slightly smaller amount of normal-size perforin than controls, plus a weak band at 55 kDa. Under non-reducing conditions to detect an active form of perforin, this active mature form was markedly reduced in the patient ( Figure 1C).…”
mentioning
confidence: 99%